|
Volumn 16, Issue 1-2, 2004, Pages 93-106
|
Bulgaria mental health country profile
|
Author keywords
[No Author keywords available]
|
Indexed keywords
FLUVOXAMINE;
HALOPERIDOL;
NEUROLEPTIC AGENT;
OLANZAPINE;
PAROXETINE;
QUETIAPINE;
RISPERIDONE;
TRICYCLIC ANTIDEPRESSANT AGENT;
VENLAFAXINE;
ALIENATION;
BIPOLAR DISORDER;
BUDGET;
BULGARIA;
CRIME;
DEMENTIA;
DEPRESSION;
DISASTER;
ECONOMIC ASPECT;
EPILEPSY;
FAMILY;
HEALTH;
HEALTH CARE NEED;
HEALTH CARE POLICY;
HEALTH INSURANCE;
HEALTH PROGRAM;
HUMAN;
HUMAN RIGHTS;
LEADERSHIP;
MENTAL DISEASE;
MENTAL HEALTH SERVICE;
MORBIDITY;
ORGANIZATION;
PRIMARY HEALTH CARE;
PRIORITY JOURNAL;
PSYCHOSIS;
QUALITY OF LIFE;
REIMBURSEMENT;
RESOURCE ALLOCATION;
REVIEW;
SCHIZOPHRENIA;
SOCIAL SUPPORT;
SOCIOPATHY;
BULGARIA;
CRIME;
FOCUS GROUPS;
HEALTH EXPENDITURES;
HEALTH POLICY;
HUMAN RIGHTS;
HUMANS;
INTERNATIONAL COOPERATION;
LEADERSHIP;
MENTAL DISORDERS;
MENTAL HEALTH SERVICES;
ORGANIZATIONAL CULTURE;
PREJUDICE;
PRIMARY HEALTH CARE;
RELIGION;
SOCIAL SUPPORT;
SOCIOECONOMIC FACTORS;
STEREOTYPING;
|
EID: 1542719639
PISSN: 09540261
EISSN: None
Source Type: Journal
DOI: 10.1080/09540260310001635140 Document Type: Review |
Times cited : (6)
|
References (10)
|